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BRIEF COMMUNICATIONS 
METOPROLOL IN MANAGEMENT OF PATIENTS WITH 
DEPRESSION AND HYPERTENSION 
S. K. CHATURVEDI
1 
Metoprolol, a moderately cardio-selec-
tive beta adrenoceptor antagonist has been 
shown to reduce heart rate and systolic 
blood pressure (Wyberg et al 1977), and 
prevent part of pressor response to psycho-
logical sttess (Taylor 1981). In potency it is 
similar to propranolol, but its relative beta 
- 1 selectivity is the basis tor its potential 
therapeutic advantage over less selective 
agents (Weiner 1980). Though propranolol 
has been used tor the treatment of anxiety 
symptoms as well as hypertension, the risk 
of developing depression is high (Bulpitt 
andBollery 1973, Simpson and Waal-Man-
ning 1971, Lishman 1978) 
Most other anti-hypertensives also pro-
duce moderate to severe degree of depres-
sion (Lishman 1978). 
McClelland (1973) reported that beta 
blockers, other than propranolol do not 
seem to induce depressive symptoms. In 
another study, none ot the 15 patients treat-
ed with metoprolol for their anxiety symp-
toms developed depression (Chaturvedi 
1985). Hence the role of metoprolol in ma-
naging concurrent depressive symptoms 
with hypertension needs to be examined. I 
would like to describe the efficacy of me-
toprolol in 5 cases who had neurotic de-
pression and hypertension. 
Method 
The age, sex, salient clinical features, 
duration ot illness, duration of follow-up 
and improvement are presented in the 
table. The patients were not selected ran-
domly, rather metoprolol was prescribed in 
doses ot 100-150 mg per day to these cases 
who had neurotic depression and hyperten-
sion. 2 of these cases had exacerbation of de-
pressive symptoms with propranolol earlier 
and in other two cases anti-hypertensive 
(adelphane) had to be stopped because of se-
condary depression. Clinical assessment was 
done during follow-up and blood pressure 
was checked regularly. None of the cases had 
any historyoi asthma in the past or present. 
Blood pressure was controlled in all 5 cases. 
No other anti-hypertensives were prescribed. 
Depressive and anxiety symptoms were mar-
kedly reduced in 3 cases and moderately re-
duced in 2 cases. None reported any depres-
sive symptoms. No other side effects were 
noticed. 
Discussion 
This report draws attention towards using 
beta selective adrenoceptor antagonists in 
managing patients suffering from depression 
and hypertension. Though there is a wide 
range ot drugs available for managing hyper-
tension most produce adverse psychological 
reactions as depression. (Simpson and Waal-
Manning 1971, Lishman, 1978). Bulpitt and 
Dollery (1973) made extensive study of side 
effects of hypotensive agents and found mo-
derate depression in more than 30 % of pa-
tients. More than 50 % of patients on propra-
nolol had sleepiness, weakness of limbs and 
increased frequency of defaecation (Bulpitt 
and Dollery 1973). In light of these the pres-
ent report encourages use of beta selective 
adrenoceptor blockers since these produce 
fewer side effects due to minimal central ac-
tion (McClelland 1973, Chaturvedi 1985). 
Because of its beneficial effects on somatic 
symptoms of anxiety (Chaturvedi 1985), meto-
prolol can be safely used in patients with anxie-
ty disorder and hypertension. Metoprolol has 
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Patient 
1. 
2. 
3. 
4. 
5. 
Age (sex) 
42(F) 
40 (M) 
32 (P) 
33 (M) 
42 (M) 
Salient Clinical 
Features 
Palpitation] 
head ache, sad 
ness, weeping 
spells. 
Sadness, sleep 
disturb arfce, 
anxiety, 
apprrnhrniion 
llradathr, sleep 
•Ircp reduced, 
sadnrts, hopeless 
ness tiredness, 
palpitations 
anxiety 
Anxiety, sad 
ness Apprchcn 
lion, Weeping 
desire, headache 
Anxiety, sad 
nets, sleep 
disturbance 
Blood Pressure 
(Initial) (After Treat-
ment) 
160/110 120/85 
180/110 140/90 
140/100 120/80 
150/105 120/85 
140/100 120/80 
Anti-hyper-
tensives 
given 
earlier 
Propranolol 
Adelphane 
Adelphtnc 
Propranolol 
Duration 
of 
Illness 
1 year 
8 yew 
4 years 
2 years 
1 yew 
Duration 
of 
Follow-uf 
4 months 
6 months 
1 year 
3 months 
3 months 
Improvement 
> 
BP controlled 
S/s-moderatc 
ly reduced 
BP controlled 
S/s-90% 
Improvement 
BP controlled 
S/s - Marked 
Improvement 
BP controlled 
S/s-modcrate 
Improvement 
BP controlled 
S/s-Marked 
Improvement 
already been proved to be relatively safe in 
patients with bronchospastic illness (Koch-
weser 1979, Gilman and Goodman 1980). 
Systematic trials with adequate research 
designs need to be conducted to assess effi-
cacy of metoprolol in anxiety and depres-
sive disorders. 
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